276: AlphaGenome: 1-Mb multimodal deep model predicts regulatory variant effects including splicing and TAL1 mechanisms
Base by Base30 Tammi

276: AlphaGenome: 1-Mb multimodal deep model predicts regulatory variant effects including splicing and TAL1 mechanisms

Avsec et al., Nature, doi:10.1038/s41586-025-10014-0 - AlphaGenome, a 1 Mb DNA deep‑learning model, predicts base‑pair‑resolution genome tracks (RNA‑seq, splicing, chromatin) and scores variant effects, achieving state‑of‑the‑art performance across modalities. Key terms: AlphaGenome, splicing, eQTL, chromatin-accessibility, 1Mb-sequence.

Study Highlights:
AlphaGenome is a unified sequence‑to‑function deep learning model trained on human and mouse genomes that consumes 1 Mb of DNA and predicts 5,930 human genome tracks across 11 modalities using a U‑Net‑inspired encoder, transformer tower and decoder. The model was pretrained with fold splits and distilled into a single student model for efficient variant scoring, enabling base‑pair resolution outputs and splice junction prediction alongside splice site usage and RNA‑seq coverage. Quantitatively, AlphaGenome outperformed or matched external models on 22 of 24 genome track tasks and on 25 of 26 variant effect benchmarks, improving eQTL sign prediction and QTL effect correlations. The multimodal outputs enable mechanistic interpretation of variants, for example recapitulating oncogenic TAL1 enhancer mutations and identifying splice‑disrupting variants.

Conclusion:
AlphaGenome provides a unified 1‑Mb multimodal, base‑resolution sequence model that substantially improves genome track and regulatory variant effect prediction and enables mechanistic, cross‑modality interpretation.

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2026-01-30.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript portions presenting AlphaGenome architecture, multimodal outputs, benchmarking, splicing, TAL1 mechanism, 3D genome, in silico mutagenesis, and limitations.
- transcript topics: AlphaGenome architecture (1 Mb input, U‑Net backbone, transformers, sequence parallelism); Multimodal genome tracks (5,930 human tracks, 1,128 mouse tracks across 11 modalities); Variant effect benchmarking (26 tasks; 25/26 ahead); Splicing variant predictions (splice sites, splice junctions, usage); TAL1 oncogene mechanism (neo-enhancer, MYB motif); 3D genome contact maps predictions

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 8
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- AlphaGenome takes input of 1 Mb DNA and predicts thousands of genome tracks across 11 modalities at base-pair resolution
- 5,930 human genome tracks and 1,128 mouse genome tracks predicted
- AlphaGenome matched or outperformed strongest external models on 25 of 26 variant-effect benchmarks
- Splicing variant predictions include splice sites, splice junctions, and splice site usage
- TAL1 oncogene mechanism recapitulated via a neo-enhancer and MYB motif
- 3D genome folding predicted via contact maps with improved performance over specialized tools

QC result: Pass.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(462)

461: Adult Ank3 loss quiets neurons and lowers a myelin protein

461: Adult Ank3 loss quiets neurons and lowers a myelin protein

Yoon et al., Proceedings of the National Academy of Sciences - ANK3, which encodes the scaffolding protein ankyrin-G, is a major risk gene for bipolar disorder and schizophrenia, yet what it does in a...

24 Syys 24min

460: The lupus variant that also sharpens antiviral defense

460: The lupus variant that also sharpens antiviral defense

Virolainen et al., The American Journal of Human Genetics - A lupus signal on chromosome 11p15 narrows to a coding haplotype in IRF7 that most people in the world carry. This study shows the risk form...

21 Syys 24min

459: Cerebral palsy genetics: 515 candidate genes, evidence for 89

459: Cerebral palsy genetics: 515 candidate genes, evidence for 89

Arterbery et al., The American Journal of Human Genetics - Hundreds of genes have been reported as causes of cerebral palsy, yet there is no agreed model of what a pathogenic variant in a child with C...

13 Syys 24min

458: Somatic or inherited? Reading TP53 risk from shared DNA

458: Somatic or inherited? Reading TP53 risk from shared DNA

MacGregor et al., The American Journal of Human Genetics - Pathogenic TP53 variants found in blood have long been read as inherited Li-Fraumeni alleles, but many turn out to be somatic clones that gre...

10 Syys 25min

457: A deletion that raises Alzheimer risk, a duplication that lowers it

457: A deletion that raises Alzheimer risk, a duplication that lowers it

Quenez O et al., The American Journal of Human Genetics - Rare copy-number variants were called from 22,319 exomes covering early-onset Alzheimer disease, late-onset disease and unaffected controls, t...

9 Syys 24min

456: Beyond exons: where heritability hides as traits get more polygenic

456: Beyond exons: where heritability hides as traits get more polygenic

Fuhrer J et al., The American Journal of Human Genetics - Across 34 complex traits and disorders, a MiXeR-based framework partitions SNP heritability over 74 functional annotations and finds that exon...

8 Syys 45min

455: Agentic genomics: the bottleneck moves from code to judgment

455: Agentic genomics: the bottleneck moves from code to judgment

Corpas M et al., Cell Genomics - A Perspective arguing that autonomous AI agents which discover, configure and chain bioinformatics operations from natural-language instructions have shifted the bottl...

7 Syys 13min

454: Efavirenz retarda a doença priônica mexendo no colesterol do cérebro [PT]

454: Efavirenz retarda a doença priônica mexendo no colesterol do cérebro [PT]

Ali T et al., JCI Insight - Um antirretroviral aprovado para HIV, dado por via oral em microdose, prolongou a sobrevida de camundongos que carregam a proteína priônica humana e foram infectados com pr...

2 Syys 17min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
rss-hereilla
tiedekulma-podcast
utelias-mieli
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-tiedetta-vai-tarinaa
docemilia
rss-duodecim-lehti
rss-bios-podcast
hippokrateen-vastaanotolla
rss-ranskaa-raakana
radio-antro
rss-politiikasta-podcast
university-of-eastern-finland
rss-radplus
rss-lihavuudesta-podcast